Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
about
Perspectives on the chemical etiology of breast cancer.Do both heterocyclic amines and omega-6 polyunsaturated fatty acids contribute to the incidence of breast cancer in postmenopausal women of the Malmö diet and cancer cohort?Genetically modified Chinese hamster ovary cells for investigating sulfotransferase-mediated cytotoxicity and mutation by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridineHuman risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acidA comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach.Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk.Mouse models of colorectal cancer.Red meat-derived heterocyclic amines increase risk of colon cancer: a population-based case-control studyEpidemiological and clinical studies of nutrition.Meat-related mutagens/carcinogens in the etiology of colorectal cancer.Chemoprevention of arylamine-induced colorectal aberrant crypts.Metabolism of Maillard reaction products by the human gut microbiota--implications for health.Isolation and characterization of human intestinal bacteria capable of transforming the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.Meat consumption, heterocyclic amines and colorectal cancer risk: the Multiethnic Cohort StudyMeat-related compounds and colorectal cancer risk by anatomical subsiteHeterocyclic amines: chemistry and health.Mouse models for the study of colon carcinogenesis.beta-catenin is strongly elevated in rat colonic epithelium following short-term intermittent treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and a high-fat diet.Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States.Inhibition of dibenzo[a,l]pyrene-induced multi-organ carcinogenesis by dietary chlorophyllin in rainbow trout.A miRNA signature for an environmental heterocyclic amine defined by a multi-organ carcinogenicity bioassay in the rat.Caffeic acid regulates LPS-induced NF-κB activation through NIK/IKK and c-Src/ERK signaling pathways in endothelial cells.Highly elevated PSA and dietary PhIP intake in a prospective clinic-based study among African Americans.Inhibition of mutagenic PhIP formation by epigallocatechin gallate via scavenging of phenylacetaldehyde.U.S. dietary exposures to heterocyclic amines.Inhibition of DNA adduct formation and mutagenic action of 3-amino-1-methyl-5h-pyrido[4,3-b]indole by chlorophyllin-chitosan in rpsL transgenic mice.Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells.Analysis of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and Its Phase I and Phase II Metabolites in Mouse Urine Using LC–UV–MS–MS
P2860
Q24811790-1D6921ED-A031-4589-B171-8E2DA71AABD5Q28287605-FDA0E8A5-B1D0-40FC-A07D-D225E97D9281Q28371778-4E9DB104-6314-4CE3-98E4-1CBE46D1940AQ30248988-00BDE820-1A6F-407A-A5A3-561777E4B90BQ31097755-37A93B94-BE6A-4F7F-B697-031A06DDC05BQ33386678-9A33FF7F-1BD6-4055-BAC4-5D5B0FF427E9Q33579734-255AED18-2BD2-4789-B6DD-135674906F57Q33710969-7322324B-5BE1-42B8-8B2C-3FC9D47D8D9EQ34065674-1F215CDF-6C83-41D1-8779-285687CFE7D5Q35806738-EB0F5212-8586-4655-AB35-305038C425AEQ36298166-E8D63BDB-D882-49B0-9E24-A67FD187499EQ36467229-2D60450F-F57F-48C5-BC05-6DD345D3CDA6Q36483060-38CB31C8-2EE4-484B-A740-DD5947FB1DA8Q36558265-6B3FAB61-C156-483E-9AB4-6E0444BD41D2Q36645047-6886CEC3-FFC6-4384-9236-DA99DB40AFE1Q36666698-F8B4DFB7-2039-41D1-88FE-585EBE676021Q37090445-DB29425F-67DF-4748-B38B-944DE8C4C063Q37416121-43A65182-A63A-45C6-8B67-6521EF6A8A32Q37432318-AA8E08EB-9E32-4E6B-A609-45FF6C7F73D9Q38532358-BD9BE485-275C-4B65-B259-01746982FAD2Q38746340-5E0C549B-B76F-4F6B-8486-0C6B299077C3Q39120121-501A6256-5788-494F-9769-4ADCAB0151B8Q39782175-EC347517-EA29-4503-9BDC-8005E1976C38Q42168159-E4771B35-3AF7-4748-80D0-A39D1A89ED72Q43690805-8E31B808-D417-4526-B651-604E4EF5BD16Q43709710-D2238FCC-C03A-4D4F-BE1E-C8964BF72273Q43938566-BED3EFE5-435C-42F1-AB9C-03313E8D0FACQ57531450-179292D8-0BE1-4223-88D9-4524F8C4D945
P2860
Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
@ast
Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
@en
Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
@nl
type
label
Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
@ast
Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
@en
Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
@nl
prefLabel
Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
@ast
Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
@en
Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
@nl
P2093
P1433
P1476
Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.
@en
P2093
A Hagiwara
R Hasegawa
P304
P356
10.1016/S0027-5107(97)00032-8
P407
P577
1997-05-01T00:00:00Z